The Patent Finder

Terms ending in 2029

Rapid Pathogen Screening, Inc.

Every in-force patent on Rapid Pathogen Screening, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,090,670Use of Peptides for Promoting Wound Healing
In force
 · High confidence
Visus Therapeutics, Inc.In forceHigh confidence
US 9,115,180Use of peptides for promoting wound healing
In force
 · High confidence
Visus Therapeutics, Inc.In forceHigh confidence
US 8,962,260Method and Device for Combined Detection of Viral and Bacterial Infections
In force
 · High confidence
Rapid Pathogen Screening, Inc.In forceHigh confidence
US 9,372,192Method And Device For Combined Detection Of Viral And Bacterial Infections
In force
 · Medium confidence
Rapid Pathogen Screening, Inc.In forceMedium confidence
US 10,808,287Improved Methods and Devices for Accurate Diagnosis of Infections
In force
 · High confidence
Rapid Pathogen Screening, Inc.In forceHigh confidence
US 9,121,849Lateral Flow Assays
In force
 · High confidence
Rapid Pathogen Screening, Inc.In forceHigh confidence
6 of 6 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Rapid Pathogen Screening, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited